This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
This article is within the scope of WikiProject Chemical and Bio Engineering, a project which is currently considered to be inactive.Chemical and Bio EngineeringWikipedia:WikiProject Chemical and Bio EngineeringTemplate:WikiProject Chemical and Bio EngineeringChemical and Bio Engineering articles
Latest comment: 12 years ago1 comment1 person in discussion
Given the significant advances in this field in the past 4 years, I plan to rewrite this article, as is suggested, in a more encyclopedic style. I welcome any comments here or on my user page. The page should overview why AAV is a good vector for retinal disease, discuss the preclinical and clinical data, most notably the UPenn RPE65 clinical trials, and go on to discuss more recent developments and clinical studies in the field in Stargardts disease, age-related macular degeneration, color blindness, choroideremia, etc. Thatbiotechguy (talk) 18:29, 29 December 2011 (UTC)ThatbiotechguyReply